Meiji Holdings Co., Ltd. (2269) Earnings Releases & Disclosures
Upcoming
- 2026-11-12 Earnings Announcement
| Date | Type | Title | Files |
|---|---|---|---|
| 2026-11-12 | Earnings Release | Consolidated Financial Results for the Second Quarter of the Fiscal Year Ending March 31, 2027 [Based on Japanese GAAP] | |
| 2026-11-12 | Treasury Shares | Notice of Decision Regarding the Repurchase of Own Shares | |
| 2026-10-06 | — | Notice Concerning Transfer of Shares of a Consolidated Subsidiary | |
| 2026-09-30 | — | Execution of JV and Share Transfer Agreement for Transfer of KYORIN Pharmaceutical’s Generic Drug Business to JV by Daito, Meiji Seika Pharma and DBJ | |
| 2026-09-25 | Treasury Shares | Notice concerning Completion of Payment in Full and Partial Forfeiture of Rights for Disposal of Treasury Stock under Restricted Stock Incentive Plan | |
| 2026-08-05 | Earnings Release | Consolidated Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2027 [Based on Japanese GAAP] | |
| 2026-07-31 | Treasury Shares | Notice concerning Completion of Payment in Full for Disposal of Treasury Stock for Restricted Stock Compensation for Directors | |
| 2026-07-21 | — | Notice Concerning Transfer of Shares of Subsidiaries Associated with Restructuring of Business Portfolio in China |
TDnet keeps only 31 days; this site accumulates daily and cannot backfill earlier disclosures.